Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 4, 1996, Pages 491-498

  Christie, Richard H ^a   Chung, Haeyong ^a   Rebeck, William ^a   Strickland, Dudley ^b   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

Alzheimer's disease; ApoE; Apolipoprotein receptors; VLDL receptor

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INTERNALIZATION; LIPID TRANSPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY; SENILE PLAQUE; TISSUE DISTRIBUTION;

EID: 0029990315     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199604000-00012     Document Type: Article

References (43)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-23
3. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342.697-99
4. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-80
5. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein E4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-16
6. Tsai M-S, Tangalos EG, Petersen RC, et al. Apoliprotein E: Risk factor for Alzheimer's disease. Am J Hum Genet 1994;54:643-49
7. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-47
8. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-66
9. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B, Apolipoprotein E: Binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Comm 1993;192:359-65
10. Wisniewski T, Frangione B. Apolipoprotein E. A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992,135:235-38
11. Strittmatter WJ, Weisgrabber KH, Goedert M, et al. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-71
12. Poirier J, Hess M, May P, Finch C. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991;11:97-106
13. Beislegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding pro tein. Nature 1989;341:162-64
14. Kowal RC, Herz J, Goldstein JL, Esser V, Brown MS. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 1989;86:5810-14
15. Saito A, Pietromonaco S, Kwor-Chieh Loo A, Farquhar MG. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci 1994;91:9725-29
16. Sakai J, Hoshino A, Takahashi S, et al. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene J Biol Chem 1994;269:2173-82
17. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci (USA) 1992;89:9252-56
18. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Gen 1995;11:207-9
19. Chung H, Roberts CT, Greenberg S, et al. Lack of association of trinucleotide repeat polymorphisms in the VLDL receptor gene with Alzheimer disease. Ann Neurol 1996;(in press)
20. Argraves K, Battey F, MacCalman C, et al. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 1996; (in press)
21. Heegaard C, Simonsen A, Oka K, et al. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator type I plasminogen activator inhibitor complex. J Biol Chem 1995;270:20855-61
22. Battey F, Gafvels M, FitzGerald D, et al. The 39-kDa Receptor-associated Protein regulates ligand binding by the Very Low Density Lipoprotein receptor. J Biol Chem 1994;269:23268-73
23. Mcdh JD, Fry GL, Bowen SL, Pladet MW, Strickland DS, Chappell DA. The 39-kDa Receptor-Associated Protein modulates lipoprotein catabolism by binding to LDL receptors. J Biol Chem 1995;270:536-40
24. Jokinen BV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH. Regulation of the Very Low Density Lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 1994;269:26411-18
25. Jentoft N. Why are proteins O-glycosylated? Trends Biochem Sci 1990;15:291-94
26. Koivisto PVI, Koivisto U-M, Miettinen TA, Kontula K. Diagnosis of Heterozygous Familial Hypercholesterolemia: DNA analysis complements clinical examination and analysis of serum levels. Arterioscler Thromb 1992;12:584-92
27. Wittmaack FM, Gåfvels ME, Bronner M, et al. Localization and regulation of the human Very Low Density Lipoprotein/Apolipoprotein-E receptor: Trophoblast expression predicts a role for the receptor in placental lipid transport. Endocnnology 1995;136:340-48
28. Zheng G, Bachinsky DR, Stamenkovic I, et al. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2MR, and the Receptor-Associated Protein (RAP). J Histochem Cytochem 1994;42:531-42
29. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
30. Mirra SS, Heyman A, McKeel D. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
31. Hyman BT, Tanzi RE, Marzloff KM, Barbour R, Schenk D. Kunitz protease inhibitor containing amyloid precursor protein immunoreactivity in Alzheimer's disease: A quantitative study. J Neuropath Exp Neurol 1992;51:76-83
32. Fleischer S, Kervina M. Subcellular fractionation of rat liver. Methods Enzymol 1974;31:6-41
33. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-55
34. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 1995;37:211-17
35. Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA 1993;7:75-83
36. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmuno 1989;24:173-82
37. Hyman B, Rebeck G, Christie R, Page K, Irizarry M, Strickland D. Apolipoprotein E and apolipoprotein receptors in the central nervous system: Relationship with Alzheimer disease. In: Roses A, Weisgraber K, Christen Y, eds. Apolipoprotein E and Alzheimer disease: IPSEN Foundation, 1996 (in press)
38. Holtzman D, Pitas R, Kilbridge J, et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci 1995;92:9480-84
39. Kounnas M, Moir R, Rebeck G, et al. LDL receptor-related protein, a multifunctional apolipoprotein E receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 1995;82:331-40
40. Strittmatter WJ, Weisgraber KH, Huang D, et al. Binding of human apolipoprotein E to BA4 peptide: Isoform-specific effects and implications for late onset Alzheimer disease. Proc Natl Acad Sci (USA) 1993;90:8098-8102
41. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 1994;269:23403-6
42. Naslund J, Thyberg J, Tjernberg L, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron 1995;15:219-28
43. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimers disease. Proc Natl Acad Sci (USA) 1993;90:9649-53